These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 26141343

  • 1. Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.
    Pernot S, Artru P, Mithieux F, Marsot J, Watkin E, Pellerin O, Lledo G, Chalabreysse P, Desramé J, Taieb J.
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):e73-7. PubMed ID: 26141343
    [Abstract] [Full Text] [Related]

  • 2. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
    Martin RC, Scoggins CR, Schreeder M, Rilling WS, Laing CJ, Tatum CM, Kelly LR, Garcia-Monaco RD, Sharma VR, Crocenzi TS, Strasberg SM.
    Cancer; 2015 Oct 15; 121(20):3649-58. PubMed ID: 26149602
    [Abstract] [Full Text] [Related]

  • 3. Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial.
    Martin RC, Scoggins CR, Tomalty D, Schreeder M, Metzger T, Tatum C, Sharma V.
    J Gastrointest Surg; 2012 Aug 15; 16(8):1531-8. PubMed ID: 22528576
    [Abstract] [Full Text] [Related]

  • 4. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.
    Richardson AJ, Laurence JM, Lam VW.
    J Vasc Interv Radiol; 2013 Aug 15; 24(8):1209-17. PubMed ID: 23885916
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
    Bhutiani N, Akinwande O, Martin RC.
    World J Surg; 2016 May 15; 40(5):1178-90. PubMed ID: 26711640
    [Abstract] [Full Text] [Related]

  • 6. PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.
    Jones RP, Malik HZ, Fenwick SW, Terlizzo M, O'Grady E, Stremitzer S, Gruenberger T, Rees M, Plant G, Figueras J, Albiol M, Adam R, Awad S, Poston GJ.
    Eur J Surg Oncol; 2016 Dec 15; 42(12):1866-1872. PubMed ID: 27561844
    [Abstract] [Full Text] [Related]

  • 7. Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization.
    Scevola G, Loreni G, Rastelli M, Sposato S, Ramponi S, Miele V.
    Med Oncol; 2017 Mar 15; 34(3):37. PubMed ID: 28160267
    [Abstract] [Full Text] [Related]

  • 8. Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases.
    Swierz MJ, Storman D, Mitus JW, Hetnal M, Kukielka A, Szlauer-Stefanska A, Pedziwiatr M, Wolff R, Kleijnen J, Bala MM.
    Cochrane Database Syst Rev; 2024 Aug 09; 8(8):CD012757. PubMed ID: 39119869
    [Abstract] [Full Text] [Related]

  • 9. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.
    Narayanan G, Barbery K, Suthar R, Guerrero G, Arora G.
    Anticancer Res; 2013 May 09; 33(5):2077-83. PubMed ID: 23645758
    [Abstract] [Full Text] [Related]

  • 10. Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study.
    Iezzi R, Marsico VA, Guerra A, Cerchiaro E, Cassano A, Basso M, Devicienti E, Rodolfino E, Barone C, Bonomo L.
    Cardiovasc Intervent Radiol; 2015 Dec 09; 38(6):1523-31. PubMed ID: 25799948
    [Abstract] [Full Text] [Related]

  • 11. Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study.
    Pernot S, Pellerin O, Artru P, Montérymard C, Smith D, Raoul JL, De La Fouchardière C, Dahan L, Guimbaud R, Sefrioui D, Jouve JL, Lepage C, Tougeron D, Taieb J, for FFCD1201-DEBIRI investigators/Collaborators.
    Br J Cancer; 2020 Aug 09; 123(4):518-524. PubMed ID: 32507854
    [Abstract] [Full Text] [Related]

  • 12. Fluorouracil, leucovorin and irinotecan combined with intra-arterial hepatic infusion of drug-eluting beads preloaded with irinotecan in unresectable colorectal liver metastases: side effects and results of a concomitant treatment schedule. Clinical investigation.
    Kekez D, Badzek S, Prejac J, Gorsic I, Golem H, Librenjak N, Perkov D, Smiljanic R, Plestina S.
    Tumori; 2014 Aug 09; 100(5):499-503. PubMed ID: 25343542
    [Abstract] [Full Text] [Related]

  • 13. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study.
    Venturini M, Sallemi C, Agostini G, Marra P, Cereda S, Reni M, Aldrighetti L, De Cobelli F, Del Maschio A.
    Br J Radiol; 2016 Nov 09; 89(1067):20160247. PubMed ID: 27558984
    [Abstract] [Full Text] [Related]

  • 14. Early Experience with 70-150 μm Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.
    Akinwande O, Scoggins C, Martin RC.
    Anticancer Res; 2016 Jul 09; 36(7):3413-8. PubMed ID: 27354601
    [Abstract] [Full Text] [Related]

  • 15. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population.
    Huppert P, Wenzel T, Wietholtz H.
    Cardiovasc Intervent Radiol; 2014 Feb 09; 37(1):154-64. PubMed ID: 23670568
    [Abstract] [Full Text] [Related]

  • 16. Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded).
    de Baere T, Tselikas L, Boige V, Ducreux M, Malka D, Goéré D, Benahim E, Deschamps F.
    Bull Cancer; 2017 May 09; 104(5):402-406. PubMed ID: 27993355
    [Abstract] [Full Text] [Related]

  • 17. Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(®)) for colorectal liver metastases does not predict tumour destruction or long-term outcome.
    Jones RP, Stättner S, Dunne DF, O'Grady E, Smethurst A, Terlizzo M, Malik HZ, Fenwick SW, Poston GJ.
    Eur J Surg Oncol; 2013 Oct 09; 39(10):1122-8. PubMed ID: 23928482
    [Abstract] [Full Text] [Related]

  • 18. Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study.
    Tanaka T, Sato T, Nishiofuku H, Masada T, Tatsumoto S, Marugami N, Otsuji T, Kanno M, Koyama F, Sho M, Kichikawa K.
    BMC Cancer; 2019 Aug 01; 19(1):758. PubMed ID: 31370815
    [Abstract] [Full Text] [Related]

  • 19. Transcatheter arterial chemoembolization using cisplatin powder mixed with degradable starch microspheres for colorectal liver metastases after FOLFOX failure: results of a phase I/II study.
    Nishiofuku H, Tanaka T, Matsuoka M, Otsuji T, Anai H, Sueyoshi S, Inaba Y, Koyama F, Sho M, Nakajima Y, Kichikawa K.
    J Vasc Interv Radiol; 2013 Jan 01; 24(1):56-65. PubMed ID: 23194749
    [Abstract] [Full Text] [Related]

  • 20. TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects.
    Fiorentini G, Aliberti C, Benea G, Montagnani F, Mambrini A, Ballardini PL, Cantore M.
    Hepatogastroenterology; 2008 Jan 01; 55(88):2077-82. PubMed ID: 19260480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.